Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01104298
What this trial is testing

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Who this might be right for
Sarcoma
Grupo Espanol de Investigacion en Sarcomas 115
Testing effectiveness (Phase 2)Looking for participantsNCT05286619
What this trial is testing

Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
University of Malaya 63
Testing effectiveness (Phase 2)UnknownNCT04224636
What this trial is testing

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ludwig-Maximilians - University of Munich 106
Testing effectiveness (Phase 2)Study completedNCT00997334
What this trial is testing

Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC

Who this might be right for
Non-small Cell Lung Cancer
David M. Jackman, MD 60
Testing effectiveness (Phase 2)Ended earlyNCT01531764
What this trial is testing

BIBW 2992 (Afatinib) and Vinorelbine

Who this might be right for
Carcinoma Breast Stage IV
University of Magdeburg 2
Not applicableStudy completedNCT02718534
What this trial is testing

Early Limb Rehabilitation Therapy Within 48 h of Acute Stroke Onset(ERTAS)

Who this might be right for
Time of First Rehabilitation Therapy
Shengjing Hospital 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04607421
What this trial is testing

Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Pfizer 841
Not applicableStudy completedNCT06975371
What this trial is testing

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Who this might be right for
Advanced/Metastatic HER2-negative Breast Cancer
Daiichi Sankyo 1,415
Not applicableUnknownNCT02055144
What this trial is testing

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 100
Testing effectiveness (Phase 2)Study completedNCT01620593
What this trial is testing

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 41
Not applicableUnknownNCT02844270
What this trial is testing

Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

Who this might be right for
Heart Diseases
Shanghai Bio-heart Biological Technology Co., Ltd. 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04656951
What this trial is testing

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Who this might be right for
Multiple Myeloma
University of Cologne 67
Large-scale testing (Phase 3)Looking for participantsNCT06838273
What this trial is testing

BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment in Patients With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04)

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 720
Not applicableLooking for participantsNCT07806786
What this trial is testing

Building Capacity and Healing: A First Nations-led Study of Education for Psychedelic-Assisted Therapy

Who this might be right for
HealthyHealthcare ProfessionalFeasibility Studies+1 more
First Nations Health and Social Secretariat of Manitoba 40
Testing effectiveness (Phase 2)Study completedNCT01951586
What this trial is testing

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Amgen 226
Large-scale testing (Phase 3)Not Yet RecruitingNCT07797283
What this trial is testing

Phase 3 Study of INCB123667 Plus Bevacizumab Versus Bevacizumab Alone as First-Line Maintenance Therapy in Ovarian Cancer Overexpressing Cyclin E1

Who this might be right for
Ovarian Cancer
Incyte Corporation 590
Not applicableStudy completedNCT00006441
What this trial is testing

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 398
Large-scale testing (Phase 3)Study completedNCT01541605
What this trial is testing

Methylphenidate for the Treatment of Acute Mania

Who this might be right for
Mania
Michael Kluge 42
Early research (Phase 1)Looking for participantsNCT06232083
What this trial is testing

A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)

Who this might be right for
Lung CancerEsophageal CancerCervical Cancer
Anhui Provincial Hospital 20
Large-scale testing (Phase 3)Study completedNCT02541383
What this trial is testing

Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Intergroupe Francophone du Myelome 1,085
Next Page